The city of El Paso, Texas, currently has 3 active clinical trials seeking participants for COVID19 research studies.
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
NCT05077917
Recruiting
The study hypothesis is that cromolyn, when combined with standard COVID-19 treatment, will improve patient symptoms and reduce the number of days to improved quality of life. Investigators will study the effects of adding cromolyn to the standard treatment of hospitalized patients with COVID-19 pneumonia and who require supplemental oxygen. Cromolyn will be administered as a nebulized treatment four times a day for four days followed by intranasal administration for two weeks. Investigators ma... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
02/21/2024
Locations: University Medical Center of El Paso, El Paso, Texas
Conditions: COVID-19 Pneumonia, COVID-19 Respiratory Infection, Pneumonia, Viral
Register for Updates
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
NCT06042855
Recruiting
The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19. Participants will receive either study drug or placebo. Participants will self-report any new or worsening symptoms or medical events experienced while taking study drug or placebo. This study is intended to be all remote with no in person visits, unless the study team feels it is in the best interest of a partic... Read More
Gender:
All
Ages:
30 years and above
Trial Updated:
02/12/2024
Locations: Texas Tech University Health Sciences Center, El Paso, Texas
Conditions: Covid19
Register for Updates
Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms?
NCT05303116
Recruiting
Since the neurologic symptoms of some COVID patients ('brain fog') resemble those of patients with concussion, the aim of this study is to identify EEG and cognitive function changes in COVID patients. We will use the FDA cleared BrainScope medical device in conjunction with standard neurocognitive tests to identify correlations with electrical biomarkers and to potentially identify new, unique patterns of altered brain electrical activity associated with COVID-19 infection. A baseline assessmen... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
06/28/2023
Locations: University Medical Center of El Paso, El Paso, Texas
Conditions: COVID-19
Register for Updates